Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Yucaipa › NPI 1043597743
Clinic

Southern California Emergency Medicine

Southern California Emergency Medicine was paid $2.13M by Medicaid between Jan 2018 and Nov 2024, across 49 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 53% of everything it billed.

33Billing provider infoSOUTHERN CALIFORNIA EMERGENCY MEDICINE
YUCAIPA, CA 92399
33aNPI1043597743assigned 11/08/2011
28Total paid$2.13M
24GClaims74,424
24DCodes billed49
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Urgent Care Clinic/Center providers in California

Rank by total paid#52 of 284
Median peer was paid$147K
This provider vs. median14×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201835,524$911K
201930,019$869K
20201,561$72K
2021295$18K
20221,593$72K
20234,541$112K
2024incomplete891$75K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 53% 29,449 26,718 $1.13M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 14% 7,573 7,200 $295K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 11% 4,195 4,130 $233K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 8.2% 2,767 2,728 $176K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 4.0% 4,082 3,880 $85K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 3.4% 973 963 $73K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1.0% 3,297 3,241 $21K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,285 1,219 $15K
87070 <1% 1,728 1,667 $13K
81002 <1% 6,350 6,044 $12K
G9920 Screening performed and negative <1% 401 401 $11K
71046 Radiologic examination, chest; 2 views <1% 379 370 $9K
37 more codes
81025 <1% 3,388 $9K
73630 <1% 211 $5K
73610 <1% 183 $5K
93000 <1% 148 $4K
99215 Doctor's office visit, returning patient (complex) <1% 66 $4K
73130 <1% 140 $4K
73110 <1% 115 $3K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,729 $3K
29540 <1% 144 $2K
0064A <1% 51 $2K
E0114 Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips <1% 53 $2K
80306 <1% 113 $2K
73562 <1% 66 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,206 $1K
A7003 Administration set, with small volume nonfiltered pneumatic nebulizer, disposable <1% 1,072 $1K
82962 <1% 507 $980.08
0004A <1% 24 $960.00
90686 <1% 51 $955.31
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 404 $873.41
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 163 $709.35
99000 <1% 192 $664.32
90714 <1% 30 $659.40
90674 <1% 23 $647.89
J3490 Unclassified drugs <1% 539 $548.44
L3908 Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf <1% 12 $521.04
10060 <1% 13 $504.24
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 66 $441.78
73140 <1% 25 $385.75
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 15 $182.70
69209 <1% 14 $159.88
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 1,064 $146.11
73560 <1% 12 $128.04
S0077 Injection, clindamycin phosphate, 300 mg <1% 18 $73.66
81003 <1% 15 $27.31
J0690 Injection, cefazolin sodium, 500 mg <1% 15 $26.24
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 12 $4.40
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 46 $2.50

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBRUNK, JENNIFER (CREDENTIALING MANAGER)
Same official

Other billing entities under BRUNK, JENNIFER

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.